XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows
¥ in Thousands, $ in Thousands
 9 Months Ended
Sep. 30, 2020
CNY (¥)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
CNY (¥)
Cash flows from operating activities      
Net loss ¥ (570,635) $ (84,045) ¥ (1,103,380)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation of property, equipment and software 7,738 1,140 6,835
Loss on disposal of property, equipment and software 8 1  
Fair value change of short-term investments (2,557) (377) (332)
Fair value change of warrants     (5,609)
Fair value change of other financial assets     145
Share-based compensation 392,576 57,820 366,885
Amortization of right-of use assets and interest of lease liabilities 6,935 1,021 4,427
Gains on deconsolidation of a subsidiary (407,598) (60,033)  
Changes in operating assets and liabilities      
Prepayments and other receivables 3,309 488 12,310
Accruals and other payables (17,623) (2,596) 32,200
Advance from customers     (14,151)
Research and development funding received     52,207
Deferred subsidy income 3,718 548 1,420
Other non-current liabilities 8,433 1,242  
Lease liabilities (6,935) (1,021) (4,950)
Net cash used in operating activities (582,631) (85,812) (651,993)
Cash flows from investing activities      
Purchase of property, equipment and software (4,761) (701) (4,617)
Proceeds from disposal of property, equipment and software     12
Proceeds from disposal of short-term investments 276,884 40,781 35,332
Purchase of short-term investments (270,853) (39,892) (88,000)
Cash disposed of resulting from deconsolidation of a subsidiary (257,651) (37,948)  
Cash received from disposal of other financial assets     192,401
Net cash generated from (used in) investing activities (256,381) (37,760) 135,128
Cash flows from financing activities      
Consideration received in advance from a preferred shares investor     70,729
Proceeds from initial public offering and over-allotment, net of underwriting discounts and commissions 726,300 106,972  
Payment of issuance cost for initial public offering and over-allotment (27,088) (3,990) (1,316)
Proceeds from private placement, net of payment of issuance cost 1,980,548 291,703  
Proceeds from exercise of stock options 791 117  
Proceeds from bank borrowings     50,000
Prepayment for stock repurchase program (34,859) (5,134)  
Repayment of bank borrowings (50,000) (7,364) (80,000)
Net cash generated from financing activities 2,595,692 382,304 39,413
Effect of exchange rate changes on cash and cash equivalents and restricted cash 10,054 1,480 77,581
Net increase (decrease) in cash and cash equivalents and restricted cash 1,766,734 260,212 (399,871)
Cash, cash equivalents, and restricted cash, beginning of year 1,193,283 175,751 1,680,931
Cash, cash equivalents, and restricted cash, end of the year 2,960,017 435,963 1,281,060
Additional ASC 842 supplemental disclosures      
Cash paid for fixed operating lease costs included in the measurement of lease obligations in operating activities 6,935 1,021 4,950
Right-of-use assets obtained in exchange for operating lease obligations 5,029 741 2,952
Other supplemental cash flow disclosures      
Interest paid 957 141 2,466
Non-cash activities      
Accrued initial public offering costs payable 508 75 ¥ 4,850
Accrued private placement offering costs payable 96,837 14,263  
Ordinary shares issued to Everest 254,848 37,535  
Conversion of preferred shares to ordinary shares ¥ 3,104,177 $ 457,196